Thema: US29479A1088
ERAS, US29479A1088
money-5338733_1920.jpg - Foto: THN
Erasca stock: RAS pipeline advances toward expanded clinical data
Erasca stock drew attention as management outlined progress for its RAS cancer pipeline at the Stifel Healthcare Conference. New clinical updates are expected soon.
ad-hoc-news.de, heute 02:40 Uhr
ERAS, US29479A1088
Erasca stock heads toward November cancer data presentations ...
Erasca stock was last at USD 14.30 on October 6, 2026, 41.1 percent below its 52-week high. Eleven brokerages set a USD 22.09 average target.
ad-hoc-news.de, 07.10.26 00:47 Uhr
ERAS, US29479A1088
Erasca announces ERAS-0015 data: what it means for Erasca ...
Phase one data showed a 57.00 percent eight-week response rate. Eight of 11 analysts rate Erasca stock a Buy, with market value at USD 5.1 billion.
ad-hoc-news.de, 06.10.26 06:05 Uhr
ERAS, US29479A1088
Erasca faces claims. JPMorgan targets Erasca stock at USD ...
A notice revisited ERAS-0015 claims on October 1, 2026. For Erasca stock, second-quarter 2026 GAAP loss reached USD 44.08 million.
ad-hoc-news.de, 02.10.26 00:47 Uhr
Institutional, Investors
Institutional Investors Show Growing Confidence in Erasca’s ...
